Natalie Welty
Janssen (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, Neuropeptides and Animal Physiology, Sleep and related disorders, Circadian rhythm and melatonin
Most-Cited Works
- → Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567(2013)193 cited
- → Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement(2010)157 cited
- → Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia(2015)81 cited
- → In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor(2009)52 cited
- → JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats(2010)47 cited
- → Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor(2019)28 cited
- → In vivo Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 Agonist(2019)17 cited
- → In vivo Calcium Imaging Reveals That Cortisol Treatment Reduces the Number of Place Cells in Thy1-GCaMP6f Transgenic Mice(2019)15 cited
- → The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortex(2009)13 cited
- → Pharmacological characterisation of JNJ‐78911118, a novel, centrally‐penetrant, selective GluN2A antagonist(2025)1 cited